Browse by Letter
Disorders - M
Maladaptive health behaviours affecting disorders or diseases classified elsewhere
All diagnostic requirements for Psychological or behavioural factors affecting transtornos or diseases classified elsewhere are met. The individual exhibits maladaptive health behaviours that adversely affect the manifestation, treatment, or course of a transtorno or disease classified in another chapter (e.g., overeating, lack of exercise).
Manic mood symptoms in primary psychotic disorders
Manic mood symptoms in primary psychotic transtornos refer to elevated, euphoric, irritable, or expansive mood states, including rapid changes among different mood states (i.e., mood lability). It also includes increased subjective experience of energy, which may be accompanied by increased goal-directed activity. The severity of associated non-mood symptoms of a Manic or Hypomanic episódio (e.g., decreased need for sleep, distractibility) should not be considered in making a rating. Increased non-goal-directed psychomotor activity should be considered as part of the rating of the 'psychomotor symptoms in primary psychotic transtornos' rather than here. This descriptor may be used whether or not the manic symptoms meet the diagnostic requirements of a separately diagnosed bipolar transtorno. The rating should be made based on the severity of manic mood symptoms during the past week.
MDMA or related drug withdrawal, including MDA
MDMA or related drug abstinência, including MDA is a clinically significant cluster of symptoms, behaviours and/or physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of uso of MDMA or related drugs in individuals who have developed MDMA or related drug dependência or have used MDMA or related drugs for a prolonged period or in large amounts. Presenting features of MDMA or related drug abstinência may include fatigue, lethargy, hypersomnia or insomnia, depressed mood, anxiety, irritability, craving, difficulty in concentrating, and appetite disturbance.
MDMA or related drug dependence, including MDA
MDMA or related drug dependência, including MDA is a transtorno of regulation of MDMA or related drug uso arising from repeated or continuous uso of MDMA or related drugs. The characteristic feature is a strong internal drive to uso MDMA or related drugs, which is manifested by impaired ability to control uso, increasing priority given to uso over other activities and persistence of uso despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to uso MDMA or related drugs. Physiological features of dependência may also be present, including tolerance to the effects of MDMA or related drugs, abstinência symptoms following cessation or reduction in uso of MDMA or related drugs, or repeated uso of MDMA or pharmacologically similar substances to prevent or alleviate abstinência symptoms. The features of dependência are usually evident over a period of at least 12 months but the diagnosis may be made if MDMA or related drug uso is continuous (daily or almost daily) for at least 3 months.
MDMA or related drug dependence, including MDA, current use
atual MDMA or related drug dependência, including MDA, com MDMA or related drug uso within the past month.
MDMA or related drug dependence, including MDA, early full remission
After a diagnosis of MDMA or related drug dependência, including MDA, and often following a treatment episódio or other intervention (including self-help intervention), the individual has been abstinent from MDMA or related drug dependência, including MDA, during a period lasting from between 1 and 12 months.
MDMA or related drug dependence, including MDA, sustained full remission
After a diagnosis of MDMA or related drug dependência, including MDA, and often following a treatment episódio or other intervention (including self-intervention), the person has been abstinent from MDMA or related drugs, including MDA, for 12 months or longer.
MDMA or related drug dependence, including MDA, sustained partial remission
After a diagnosis of MDMA or related drug dependência, including MDA, and often following a treatment episódio or other intervention (including self-help intervention), there is a significant reduction in consumption of MDMA or related drugs, including MDA, for more than 12 months, such that even though intermittent or continuing uso of MDMA or related drugs, including MDA, has occurred during this period, the definitional requirements for dependência have not been met.
MDMA or related drug intoxication, including MDA
MDMA or related drug intoxicação, including MDA is a clinically significant transient condition that develops during or shortly after the consumption of MDMA or related drugs that is characterised by disturbances in consciousness, cognition, perception, affect, behaviour, or coordination. These disturbances are caused by the known pharmacological effects of MDMA or related drugs and their intensity is closely related to the amount of MDMA or a related drug consumed. They are time-limited and abate as MDMA or a related drug is cleared from the body. Presenting features may include increased or inappropriate sexual interest and activity, anxiety, restlessness, agitation, and sweating. In rare instances, usually in grave intoxicação, uso of MDMA or related drugs, including MDA can result in dystonia and seizures. Sudden death is a rare but recognised complication.
MDMA or related drug-induced anxiety disorder
MDMA or related drug-induced anxiety transtorno, including MDA is characterised by anxiety symptoms (e.g., apprehension or worry, fear, physiological symptoms of excessive autonomic arousal, avoidance behaviour) that develop during or soon after intoxicação com MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of anxiety symptoms that are characteristic of MDMA or related drug intoxicação, including MDA. The amount and duration of MDMA or related drug uso must be capable of producing anxiety symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., an Anxiety and fear-related transtorno, a Depressive transtorno com prominent anxiety symptoms), as might be the case if the anxiety symptoms preceded the onset of the MDMA or related drug uso, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug uso, or if there is other evidence of a pre-existing primary mental transtorno com anxiety symptoms (e.g., a history of prior episodes not associated com MDMA or related drug uso).
MDMA or related drug-induced delirium, including MDA
MDMA or related drug-induced Delirium, including MDA is characterised by an acute state of disturbed attention and awareness com specific features of Delirium that develops during or soon after substance intoxicação or during the uso of MDMA or related drugs. The amount and duration of MDMA or related drug uso must be capable of producing Delirium. The symptoms are not better explained by a primary mental transtorno, by uso of or abstinência from a different substance, or by another health condition that is not classified under Mental, behavioural and Transtornos do neurodesenvolvimento.
MDMA or related drug-induced mood disorder, including MDA
MDMA or related drug-induced mood transtorno, including MDA is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxicação com MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of MDMA or related drug intoxicação, including MDA. The amount and duration of MDMA or related drug uso must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., a Depressive transtorno, a Bipolar transtorno, Transtorno esquizoafetivo), as might be the case if the mood symptoms preceded the onset of the MDMA or related drug uso, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug uso, or if there is other evidence of a pre-existing primary mental transtorno com mood symptoms (e.g., a history of prior episodes not associated com MDMA or related drug uso).
MDMA or related drug-induced psychotic disorder, including MDA
MDMA or related drug-induced psychotic transtorno, including MDA is characterised by psychotic symptoms (e.g., delusions, hallucinations, disorganised thinking, grossly disorganised behaviour) that develop during or soon after intoxicação com MDMA or related drugs. The intensity or duration of the symptoms is substantially in excess of psychotic-like disturbances of perception, cognition, or behaviour that are characteristic of MDMA or related drug intoxicação. The amount and duration of MDMA or related drug uso must be capable of producing psychotic symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., Esquizofrenia, a Mood transtorno com psychotic symptoms), as might be the case if the psychotic symptoms preceded the onset of the MDMA or related drug uso, if the symptoms persist for a substantial period of time after cessation of the MDMA or related drug uso, or if there is other evidence of a pre-existing primary mental transtorno com psychotic symptoms (e.g., a history of prior episodes not associated com MDMA or related drug uso, including MDA).
Mental disorder affecting disorders or diseases classified elsewhere
All diagnostic requirements for Psychological or behavioural factors affecting transtornos or diseases classified elsewhere are met. The individual is diagnosed com a mental, behavioural, or neurodevelopmental transtorno that adversely affects the manifestation, treatment, or course of a transtorno or disease classified in another chapter (e.g., a woman com Bulimia nervosa and Type 1 diabetes mellitus who skips insulin doses as a way to avoid weight gain that would otherwise be caused by her binge eating).
Moderate bodily distress disorder
All definitional requirements of bodily distress transtorno are present. There is persistent preoccupation com the distressing symptoms and their consequences (e.g., the individual spends more than an hour a day thinking about them), typically associated com frequent medical visits. The person devotes much of his or her energy to focusing on the symptoms and their consequences. The symptoms and associated distress and preoccupation cause moderado impairment in personal, family, social, educational, occupational, or other important areas of functioning (e.g., relationship conflict, performance problems at work, abandonment of a range of social and leisure activities).
Moderate personality disorder
All general diagnostic requirements for Transtorno de personalidade are met. Disturbances affect multiple areas of personality functioning (e.g., identity or sense of self, ability to form intimate relationships, ability to control impulses and modulate behaviour). However, some areas of personality functioning may be relatively less affected. There are marked problems in most interpersonal relationships and the performance of most expected social and occupational roles is compromised to some degree. Relationships are likely to be characterised by conflict, avoidance, abstinência, or extreme dependency (e.g., few friendships maintained, persistent conflict in work relationships and consequent occupational problems, romantic relationships characterised by serious disruption or inappropriate submissiveness). Specific manifestations of personality disturbance are generally of moderado severity. moderado Transtorno de personalidade is sometimes associated com harm to self or others, and is associated com marked impairment in personal, family, social, educational, occupational or other important areas of functioning, although functioning in circumscribed areas may be maintained.
Mood symptoms in dementia
In addition to the cognitive disturbances characteristic of Demência, the atual clinical picture includes clinically significant mood symptoms such as depressed mood, elevated mood, or irritable mood.
Mood disorder induced by multiple specified psychoactive substances
Mood transtorno induced by multiple specified psychoactive substances is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxicação com or abstinência from multiple specified psychoactive substances. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of intoxicação com or abstinência from multiple specified psychoactive substances. The amount and duration of uso of the multiple specified psychoactive substances must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., a Depressive transtorno, a Bipolar transtorno, Transtorno esquizoafetivo), as might be the case if the mood symptoms preceded the onset of the uso of the multiple specified psychoactive substances, if the symptoms persist for a substantial period of time after cessation of the uso of the multiple specified psychoactive substances or abstinência from the multiple specified psychoactive substances, or if there is other evidence of a pre-existing primary mental transtorno com mood symptoms (e.g., a history of prior episodes not associated com the uso of the multiple specified psychoactive substances).
Mood disorder induced by other specified psychoactive substance
Mood transtorno induced by outro especificado psychoactive substance is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxicação com or abstinência from a specified psychoactive substance. The intensity or duration of the symptoms is substantially in excess of mood disturbances that are characteristic of intoxicação com or abstinência from a specified psychoactive substance. The amount and duration of uso of the specified psychoactive substance must be capable of producing mood symptoms. The symptoms are not better explained by a primary mental transtorno (e.g., a Depressive transtorno, a Bipolar transtorno, Transtorno esquizoafetivo), as might be the case if the mood symptoms preceded the onset of the uso of the specified psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the uso of the specified psychoactive substance or abstinência from the specified psychoactive substance, or if there is other evidence of a pre-existing primary mental transtorno com mood symptoms (e.g., a history of prior episodes not associated com the uso of the specified psychoactive substance).
Mood disorder induced by unknown or unspecified psychoactive substance
Mood transtorno induced by unknown or não especificado psychoactive substance is characterised by mood symptoms (e.g., depressed or elevated mood, decreased engagement in pleasurable activities, increased or decreased energy levels) that develop during or soon after intoxicação com or abstinência from a specified psychoactive substance. The symptoms are not better explained by a primary mental transtorno (e.g., a Depressive transtorno, a Bipolar transtorno, Transtorno esquizoafetivo), as might be the case if the mood symptoms preceded the onset of the uso of the unknown or não especificado psychoactive substance, if the symptoms persist for a substantial period of time after cessation of the uso of the unknown or não especificado psychoactive substance or abstinência from the unknown or não especificado psychoactive substance, or if there is other evidence of a pre-existing primary mental transtorno com mood symptoms (e.g., a history of prior episodes not associated com the uso of the unknown or não especificado psychoactive substance).
Multiple specified psychoactive substances withdrawal
Multiple specified psychoactive substance abstinência is a clinically significant cluster of symptoms, behaviours and physiological features, varying in degree of severity and duration, that occurs upon cessation or reduction of uso of multiple specified substances in individuals who have developed dependência or have used the specified substances for a prolonged period or in large amounts. Multiple specified psychoactive substance abstinência can also occur when prescribed psychoactive medications have been used in standard therapeutic doses. The specific features of the abstinência state depend on the pharmacological properties of the specified substances and their interactions.
Multiple specified psychoactive substances withdrawal, with perceptual disturbances
Multiple specified psychoactive substances withdrawal, with perceptual disturbances and seizures
Multiple specified psychoactive substances withdrawal, with seizures
Multiple specified psychoactive substances withdrawal, uncomplicated
Multiple specified psychoactive substances dependence
Multiple specified psychoactive substance dependência is a transtorno of regulation of uso of multiple specified substances arising from repeated or continuous uso of the specified substances. The characteristic feature is a strong internal drive to uso the specified substances, which is manifested by impaired ability to control uso, increasing priority given to uso over other activities and persistence of uso despite harm or negative consequences. These experiences are often accompanied by a subjective sensation of urge or craving to uso the specified substances. Physiological features of dependência may also be present, including tolerance to the effects of the specified substances, abstinência symptoms following cessation or reduction in uso of the specified substances, or repeated uso of the specified substances or pharmacologically similar substances to prevent or alleviate abstinência symptoms. The features of dependência are usually evident over a period of at least 12 months but the diagnosis may be made if uso of the specified substances is continuous (daily or almost daily) for at least 3 months.
Multiple specified psychoactive substances dependence, current use
Multiple specified psychoactive substances dependence, early full remission
Multiple specified psychoactive substances dependence, sustained full remission
Multiple specified psychoactive substances dependence, sustained partial remission
Selective mutism
Mutismo seletivo is characterised by consistent selectivity in speaking, such that a child demonstrates adequate language competence in specific social situations, typically at home, but consistently fails to speak in others, typically at school. The disturbance lasts for at least one month, is not limited to the first month of school, and is of sufficient severity to interfere com educational achievement or com social communication. Failure to speak is not due to a lack of knowledge of, or comfort com, the spoken language required in the social situation (e.g. a different language spoken at school than at home).